January 9, 2024 by Scott Melville
CHPA, Health care outlook 2024: Scott Melville, president and CEO
January 22, 2024, Opinion, Pharmacy
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The year 2023 marked another significant milestone for consumer health care with the continued growth of self-care driving the demand for safe and beneficial over-the-counter medicines, dietary supplements and consumer medical devices. Americans are prioritizing
August 14, 2023 by Chain Drug Review
CHPA, Family Dollar, self-care
Leading Headlines, Retail News
WASHINGTON – The Consumer Healthcare Products Association (CHPA) Educational Foundation and Family Dollar have launched a program to help the chain’s shoppers make informed, educated choices about choosing and using over-the-counter products and dietary supplements. The program, “Health In Hand”, is the foundation’s first-ever collaboration of this scale to help build confidence and understanding during
December 23, 2022 by Chain Drug Review
CHPA
Leading Headlines, Supplier News
WASHINGTON – The Consumer Healthcare Products Association (CHPA) today released the below statement following congressional passage of a $1.7 trillion government funding bill: “We applaud today’s passage of the Fiscal Year 2023 omnibus appropriations bill, which includes several CHPA-backed measures. CHPA is pleased that legislators prioritized measures that will advance consumer safety and protection, a critical
November 17, 2022 by Chain Drug Review
CHPA, Loucks, Sanofi
Leading Headlines, Supplier News
NEW YORK — Andrew Loucks, head of North American consumer healthcare at Sanofi, was elected to the Consumer Healthcare Products Association’s (CHPA) board of directors at its meeting here Thursday. Loucks has been in his current role at Sanofi since his appointment in August. “We very much look forward to Andrew’s participation on the CHPA
November 17, 2022 by Chain Drug Review
CHPA
Leading Headlines, Supplier News
NEW YORK – The Consumer Healthcare Products Association (CHPA) Educational Foundation held its 7th Annual Gala last night at the Plaza Hotel in New York City. The widely attended event was a sweeping success, raising 45 percent more in donations compared to 2021, and bringing together 350 attendees from 82 companies across the self-care industry. The event
November 14, 2022 by Chain Drug Review
CHPA
Leading Headlines, Retail News
WASHINGTON – The Consumer Healthcare Products Association (CHPA) Educational Foundation announced on Monday an educational pilot launch to help consumers choose over-the-counter (OTC) pain relievers at the point of purchase. Featuring signage at nearly 19,000 Dollar General stores in 47 states, the campaign reflects the Foundation’s partnership with three CHPA member companies and Foundation supporters: Haleon, makers
October 27, 2022 by Chain Drug Review
CHPA
Supplier News
WASHINGTON — Jay Sirois, CHPA’s vice president of regulatory & scientific affairs, and co-author of the paper,Considerations for determining safety of probiotics: A USP perspective, recently published in the Journal of Regulatory Toxicology and Pharmacology, released the following statement regarding the publication: “While safety assessments for many current probiotic species are backed by a solid history of safe
September 30, 2022 by Chain Drug Review
CHPA, Scott Melville
Leading Headlines, Supplier News
WASHINGTON – Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, on Friday released the below statement following congressional passage of a short-term spending package to fund the Federal Government through Dec. 16. Included in this Continuing Resolution is legislation to reauthorize the U.S. Food and Drug Administration’s (FDA) user fee programs for prescription
September 20, 2022 by Chain Drug Review
CHPA
Leading Headlines, Supplier News
BETHESDA, Md. – The Consumer Healthcare Products Association (CHPA) announced Tuesday its first-ever Regulatory & Scientific Affairs Career Achievement Award winners at its annual Regulatory, Scientific & Quality (RSQ) conference in Bethesda. Created to honor individuals maintaining a career of exceptional service and contributions withinthe consumer healthcare products industry, the establishment of this award and
September 14, 2022 by Chain Drug Review
CHPA
Leading Headlines, Supplier News
WASHINGTON — Consumer Healthcare Products Association (CHPA) senior vice president of Dietary Supplements Duffy MacKay today released the following statement in response to results from a recent COSMOS-Mind study, published in Alzheimer & Dementia Journal, revealing statistically significant improvement on global cognition in participants who took a multivitamin over the course of the long-term clinical
September 12, 2022 by Chain Drug Review
CHPA, Scott Melville
Leading Headlines, Supplier News
WASHINGTON, DC) – Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, today released the following statement in response to the U.S. Food and Drug Administration’s (FDA) announcement of a joint meeting between its Advisory Committees on Nonprescription Drugs and Obstetrics and Reproductive and Urologic Drugs. The meeting has been scheduled for Nov. 18,
September 8, 2022 by Chain Drug Review
CHPA
Leading Headlines, Supplier News
WASHINGTON – The Consumer Healthcare Products Association (CHPA) Educational Foundation today released the following statement announcing the 2022 U.S. Self-Care Marketing Awards finalists. Winners will be announced at the Seventh Annual CHPA Educational Foundation Gala on November 16 at The Plaza Hotel in New York City. “Each year, we are increasingly impressed by the
August 17, 2022 by Chain Drug Review
CHPA, Scott Melville is president and chief executive officer of the Consumer Healthcare Products Association
Supplier News
WASHINGTON — The Consumer Healthcare Products Association (CHPA) released the following statement upon the U.S. Food and Drug Administration (FDA) final rule establishing a regulatory category for over-the-counter (OTC) hearing aids: “Consumer medical devices and other OTC products provide Americans with accessible, affordable, and trusted personal healthcare products, and now FDA has opened the door to
July 29, 2022 by Chain Drug Review
CHPA, Scott Melville is the president and chief executive officer at the Consumer Healthcare Products Association.
Leading Headlines, Supplier News
WASHINGTON – Consumer Healthcare Products Association (CHPA) president and CEO Scott Melville released the below statement Friday in response to a recent report published in the Journal of the American Medical Association (JAMA): “There can be no tolerance for illegal products masquerading as dietary supplements, especially after a manufacturer has already received an FDA warning letter.